SKYE
Skye Bioscience, Inc.
1.80$
+5.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +4.1% | +9.5% | +5.2% | +2.2% | -15.1% | -1.5% | -2.9% | +8.1% | +121.5% | +165.6% | +1.2% | +5.5% | – | – | -4.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +226.9% | -65.0% | -34.1% | +46.0% | -20.9% | -64.3% | – | – | +253.2% | +35.1% | +114.4% | -25.4% | +39.6% | +11.7% | -46.4% | -19.2% | +6.7% | +65.1% | +44.5% | -62.8% | +239.7% | +13.7% | +12.8% | +24.8% | -13.7% | -22.9% | +50.9% | -29.8% | +26.8% | +22.3% | +109.5% | +19.7% | +59.6% | -7.6% | +99.2% | -34.7% | +22.6% | -32.3% | -49.2% | – | |
| – | -16.3% | +98.5% | -48.0% | +0.4% | +36.2% | +33.8% | -11.9% | -9.4% | +10.2% | +10.8% | -9.3% | -8.6% | +13.9% | +25.2% | -43.9% | +50.5% | -20.4% | +18.8% | -15.8% | +57.2% | -9.6% | +20.3% | +10.4% | -36.3% | +35.1% | +24.3% | -37.0% | +85.3% | +11.6% | +68.6% | +2.9% | +7.2% | -1.8% | +0.2% | -14.4% | +0.0% | -12.3% | +38.3% | -18.3% | – | |
| – | +6.5% | +51.3% | -47.0% | +4.2% | +29.5% | +26.8% | -13.7% | -3.1% | +25.7% | +15.2% | +16.9% | -15.1% | +22.7% | +19.9% | -44.8% | +26.0% | -14.3% | +31.8% | +5.3% | -0.6% | +35.3% | +17.3% | +11.4% | -9.2% | +217.7% | -66.6% | -8.3% | +769.0% | -83.5% | +50.6% | +36.6% | -40.9% | +114.7% | +10.3% | +55.1% | -27.3% | +12.3% | -16.1% | -11.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +134.4% | – | – | – | – | – | -99.8% | +1,420,170.3% | -94.6% | +103.4% | +153.3% | +2.6% | -4.1% | -42.5% | +3.2% | +6.4% | +1.7% | -0.5% | +2.8% | +2.8% | +1.8% | +0.1% | +3.1% | +2.9% | -19.6% | -89.2% | +913.4% | +45.5% | +58.5% | +1.6% | +3.0% | -35.3% | +47.3% | -99.7% | -100.0% | – | – | – | +50.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -131.0% | – | -148.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +107.8% | +92.5% | -17,693.6% | – | – | -100.0% | +63,907.3% | +366.9% | +170.2% | -100.0% | +214,150.7% | -295.3% | – | -98.8% | -15,195.2% | – | +131.1% | -99.6% | +256.8% | -91.2% | +30,975.6% | -96.7% | +3,887.6% | -99.2% | +43,037.0% | -99.5% | +8,005.9% | -436.5% | – | +303.6% | – | – | – | +70.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -131.0% | – | -148.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -128.6% | – | -142.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.